Pharmaceutical company AbbVie buying ImmunoGen in $10.1... :

Pharmaceutical company AbbVie is buying ImmunoGen in a deal valued at about $10.1 billion that will speed up its entry into the commercial market for ovarian cancer

Related Keywords

Richard Gonzalez , Immunogen Inc , Vie Chairman ,